Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised

PSUSA/00002052/202410

Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR): Naveruclif, paclitaxel, Date of authorisation: 05/01/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Sogroya, somapacitan, Date of authorisation: 31/03/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Zometa, zoledronic acid, Date of authorisation: 20/03/2001, Revision: 40, Status: Authorised

European Medicines Agency Write PMS API implementation Guide (zip)

European Medicines Agency Write PMS API implementation Guide

Human medicines European public assessment report (EPAR): Jinarc, tolvaptan, Date of authorisation: 27/05/2015, Revision: 24, Status: Authorised